在动脉样硬化病原发生过程中,热的作用
Xiaohan Liu1, Peiyi Luo2, Weiyun Zhang2
1Pathogen Biology Experimental Center, College of Medicine, Nanchang University, Jiangxi 330000, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 29, 2023
概括
热,一种细胞死亡形式,通过炎症血管驱动动动脉硬化 (AS). 了解热的途径可能会揭示心血管事件的新治疗方法.
科学领域:
- 生物医学科学 生物医学科学
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
背景情况:
- 热是一种涉及气体皮肤孔的亲炎性调节细胞死亡 (RCD).
- 热症越来越多地与动脉样硬化 (AS) 的发展和进展有关.
- 内皮细胞 (ECs),巨细胞和光滑肌肉细胞 (SMCs) 是通过热致死在AS中的关键参与者.
研究的目的:
- 审查动脉样硬化中的新型炎症亡途径和机制.
- 探索热在AS病变发生中的作用.
- 为了确定潜在的治疗点和药物对AS.
主要方法:
- 关于热和动脉样硬化的最新研究的文献综述.
- 分析分子通路和细胞机制的分析涉及到热.
- 综合了有关热和心血管事件之间的联系的信息.
主要成果:
- 热死通过诱导炎症和斑块不稳定性,有助于AS.
- 烧会加剧动脉硬化病变中的炎症反应.
- 热可以导致斑块破裂,血栓形成,以及急性心血管事件.
结论:
- 热是动脉样硬化病变发生的关键媒介.
- 向热的途径为AS提供了潜在的治疗策略.
- 对烧死机制的进一步研究可能会为心血管疾病提供新的治疗方法.
相关概念视频
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Inflammation
53.8K
Overview
53.8K
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13


